-The Economic Times MUMBAI: India's strong stance on minor drug innovations could reverberate in national parliaments and courthouses of the developed world as Australia, the EU and Canada get ready to discuss and ban patent protection for frivolous improvements. A top Australian government body on Wednesday asked for changes in its patent laws relating to drugs saying that the indiscriminate grant of patents to incremental innovations should be checked and that...

-The Business Standard Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up Though the India office here of Swiss pharma giant Novartis wore a gloomy look following the Supreme Court rejection of its Glivec patent application, Indian pharmaceutical companies and patients' associations are in celebration mood. D G Shah, secretary general, The Indian Pharmaceutical Alliance (IPA), comprising leading research-based Indian pharma companies, said,...

-The Hindu   When the Supreme Court has recognised the right to go on hunger strike, why is Irom Sharmila's protest against impunity of the armed forces a criminal act? Over the past 12 years, Irom Sharmila Chanu has carried on an inconceivable hunger strike, which has seen her body wither and her skin turn pale. During this period, she has emerged as the face of the civilian resistance to the immunity, and...

-The Times of India MUMBAI: Tax authorities will intensify their efforts to crack down on unaccounted-for money stashed overseas by seeking information from their counterparts in other countries. A recent letter issued by the Chairperson, Central Board of Direct Taxes (CBDT) bears testimony to this intention. To ensure that Indian tax authorities have access to information from other countries and can thus tackle the menace of black money and tax avoidance, several...

-The Telegraph Many Indians stand in solidarity with the protest launched by the academic community in the University of Pennsylvania against the decision to invite Narendra Modi, writes Prasenjit Bose S L. Rao's criticisms of the academics of the University of Pennsylvania, who had initiated a campaign against Wharton Business School's invitation to Narendra Modi, in his article, "The trip that never was" (March 18), are not only unwarranted but they also...